STI Medical Systems, a Honolulu-based company, will be among the firms presenting information for investors at a conference to be held in Paris in April.

STI is developing technology for detecting, diagnosing and treating cancer. It will be one the medical device companies presenting at "Investment in Innovation (In3) Europe." The April 29 to 30 conference will showcase promising firms who are interested in raising funding or forming strategic partnerships.